Aviva
HRMY icon

Aviva’s Harmony Biosciences HRMY Stock Holding History

Aviva’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Buy
14,997
+1,560
+12% +$51.2K ﹤0.01% 773
2025
Q4 		$503K Sell
13,437
-1,555
-10% -$51.1K ﹤0.01% 750
2025
Q3 		$413K Buy
14,992
+1,333
+10% +$45.9K ﹤0.01% 845
2025
Q2 		$432K Sell
13,659
-4,221
-24% -$136K ﹤0.01% 843
2025
Q1 		$593K Sell
17,880
-192
-1% -$6.88K ﹤0.01% 720
2024
Q4 		$622K Buy
18,072
+686
+4% +$23.6K ﹤0.01% 675
2024
Q3 		$695K Sell
17,386
-3,730
-18% -$131K ﹤0.01% 666
2024
Q2 		$637K Buy
21,116
+1,345
+7% +$40.4K ﹤0.01% 723
2024
Q1 		$664K Sell
19,771
-475
-2% -$15.2K ﹤0.01% 752
2023
Q4 		$654K Buy
+20,246
New +$565K ﹤0.01% 781

Other funds holding HRMY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return